Survival deficits in young women with breast cancer in sub-Saharan Africa

Disparities in outcomes

young women with breast cancer

Υoung women with breast cancer

 

An IARC-led cohort study revealed striking survival gaps for young women diagnosed with breast cancer in sub-Saharan Africa. Among more than 2,000 women followed in five countries, over 20% were under the age of 40, and this group had markedly poorer survival than older patients. The disadvantage was most pronounced in women diagnosed within three years of childbirth, suggesting a mix of biological vulnerability and delayed care. Factors like limited access to treatment, late diagnosis, and systemic inequities compound the risk. The study ruled out HIV status and tumour subtype as full explanations for these outcomes. The results emphasise the need for early detection programmes and tailored support for young mothers facing breast cancer in resource-limited settings.

🔗 Read More…

#EuCanScreen #CancerScreening #HealthCare #CancerPrevention #YoungWomenCancer #BreastCancer

Subscribe to our newsletter to get news and updates.

Subscribe to our newsletter to get news and updates.

Logo EU EUCanScreen Vertical

 

Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor HADEA can be held responsible for them.

tiktok

FaceBook

X

Instagram

YouTube

LinkedIn

email

EUCanScreenLogo t

The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.

FaceBook

Twitter

Instagram

YouTube

LinkedIn

Logo EU tr

This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959

Μετάβαση στο περιεχόμενο